Immunotherapy & Immuno-oncology
PART OF NEXTGEN BIOMED 2025
12 - 14 March 2025 | London, UK
NextGen Biomed 2025
A carefully curated event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of novel immunotherapies; advances in cellular, antibody and combination therapy development as well as personalised cancer therapy treatments.
Hear from past attendees of last year's Biologics 2024 conference
Gain valuable insights into advancing immunotherapy strategies to treat cancer & autoimmune diseases. Presentations will cover the current immunotherapy strategies, latest innovations in cancer immunotherapy, cytokine therapies & anti T cell therapies.
Discover the microbiome & the gut immune axis. Take a deep dive into understanding the relationship between the microbiome and cancer to transform immune-modulating therapies; the role of microbiota in metabolisms & immunity as well as novel technologies for microbiome analysis.
Hear from opinion leaders on personalised cancer therapies. Hear about advancements in cancer vaccine development, vaccines for non-infectious diseases and neoantigen identification strategies.
Explore predictive models & tools for preclinical evaluation and translational development. Thought-leaders will be discussing humanized and 3D models, maximizing translatability through effective in vitro and in vivo models and the role of the tumour microenvironment in ensuring clinical success.
leading pharma, biotech, regulatory & academic delegates
Agenda at a Glance
Immunotherapy & Immuno-oncology
DAY ONE - 12 MARCH
Track 7: Immunotherapy Strategies
Track 8: Discovery & Development: Cell & Gene and Combination Therapies
Track 9: Biomarkers, ctDNA, Precision Medicine & Multi-Omics In Immuno-Oncology
DAY TWO - 13 MARCH
Track 7: New Clinical Development for Immunotherapies
Track 8: Predictive Models & Tools for Preclinical Evaluation and Translational Development
Track 9: Personalised Cancer Therapies
DAY THREE - 14 MARCH
Track 7: Microbiome & the Gut-Immune Axis
Track 8: Discovery & Development: Antibody Therapies
Track 9: Novel Targets in Immuno-oncology: Identification, Validation & Exploration
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.